Study Links Ozempic and Wegovy to Reduced Depression and Anxiety Risk
A longitudinal study of nearly 100,000 people over more than a decade found that GLP‑1 drugs such as semaglutide (Ozempic, Wegovy) were associated with markedly fewer psychiatric hospital visits and fewer sick‑days. The findings suggest these diabetes and weight‑loss medications may also provide mental‑health benefits. The research was reported by ScienceDaily.